Bioventus (BVS) Non Operating Income (2020 - 2026)

Bioventus' Non Operating Income history runs 7 years deep, the most recent figure standing at -$3.9 million for Q1 2026.

• Quarterly Non Operating Income rose 48.08% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.7 million (up 36.67% YoY) and the FY2025 annual result came in at -$26.5 million, up 28.7% from the prior year.
• Non Operating Income was -$3.9 million for Q1 2026 at Bioventus, down from -$3.6 million in the prior quarter.
• Across five years, Non Operating Income topped out at $1.5 million in Q2 2022 and bottomed at -$10.9 million in Q4 2023.
• A 5-year average of -$6.9 million and a median of -$7.8 million in 2024 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2023 — Non Operating Income sank 622.97% — and 2025, when it jumped 54.06%.
• Bioventus' Non Operating Income stood at -$7.0 million in 2022, then plunged by 54.43% to -$10.9 million in 2023, then gained by 28.59% to -$7.8 million in 2024, then soared by 54.06% to -$3.6 million in 2025, then dropped by 9.43% to -$3.9 million in 2026.
• Business Quant data shows BVS's Non Operating Income at -$3.9 million in Q1 2026, -$3.6 million in Q4 2025, and -$6.2 million in Q3 2025.